Michael Wermann

Title: Michael Wermann: Innovator in Pharmaceutical Research

Introduction

Michael Wermann is a notable inventor based in Halle, Germany. He has made significant contributions to the field of pharmaceutical research, particularly in the development of novel compounds for medical applications. His work focuses on inhibitors of meprin α and β, which are crucial in treating various diseases.

Latest Patents

Wermann holds a patent for "Inhibitors of meprin α and β." This invention relates to novel hydroxamic acid derivatives that serve as inhibitors of meprin β and/or α. The patent also includes pharmaceutical compositions comprising these compounds, along with methods for the treatment or prophylaxis of diseases related to meprin β and/or α.

Career Highlights

Michael Wermann is currently associated with Vivoryon Therapeutics N.V., a company dedicated to developing innovative therapies for serious diseases. His expertise in pharmaceutical chemistry has been instrumental in advancing the company's research initiatives.

Collaborations

Wermann collaborates with Mirko Buchholz, a fellow researcher, to further explore the potential of their inventions in the pharmaceutical industry.

Conclusion

Michael Wermann's contributions to pharmaceutical research and his innovative patent on meprin inhibitors highlight his role as a key figure in the field. His work continues to pave the way for advancements in medical treatments.